CytoDyn's total assets for Q4 2026 were $13.97M, a decrease of -24.46% from the previous quarter. DE:296 total liabilities were $123.69M for the fiscal quarter, a 0.74% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.